Σφακιανάκης Αλέξανδρος
ΩτοΡινοΛαρυγγολόγος
Αναπαύσεως 5 Άγιος Νικόλαος
Κρήτη 72100
00302841026182
00306932607174
alsfakia@gmail.com

Αρχειοθήκη ιστολογίου

! # Ola via Alexandros G.Sfakianakis on Inoreader

Η λίστα ιστολογίων μου

Τρίτη 14 Ιουνίου 2016

Spine


Spine

Lumbar spinal atypical teratoid rhabdoid tumor.

Dhir A, Tekautz T, Recinos V, Murphy E, Prayson Ra, Ruggieri P, Wolff J · Tuesday, June 14, 2016, 14:51
http:--linkinghub.elsevier.com-ihub-imag Related Articles
Lumbar spinal atypical teratoid rhabdoid tumor.
J Clin Neurosci. 2015 Dec;22(12):1988-9
Authors: Dhir A, Tekautz T, Recinos V, Murphy E, Prayson RA, Ruggieri P, Wolff J
Abstract
We describe a pediatric patient with an atypical teratoid rhabdoid tumor (AT/RT) exclusively of the lumbar spine, with a different presentation from the two previously reported pediatric lumbar AT/RT. AT/RT are rare pediatric tumors of the central nervous system, with a dismal prognosis. Although there is sufficient literature on brain AT/RT, spinal AT/RT continues to be a rare entity, with a lumbar location even less frequently reported. A 30-month-old African American boy with multiple comorbidities presented with the inability to ambulate, encopresis and urinary dribbling. The MRI showed an intradural extramedullary mass extending downwards from the L3-4 level. He underwent an L3-S2 laminoplasty. The surgically resected mass was marked by sheets of cells with large nuclei and prominent nucleoli. The tumor cells stained with antibodies to synaptophysin and CAM5.2, and showed no immunoreactivity to INI-1 antibody. He was diagnosed with a World Health Organization Grade IV AT/RT. There was no mutation detected in the SMARCB1 gene on a comprehensive analysis of his blood. The boy is currently being treated according to the Medical University of Vienna AT/RT protocol, with no evidence of tumor recurrence 8 months after surgery. To our knowledge, this is the only report of a lumbar AT/RT in an African American child.
PMID: 26234633 [PubMed - indexed for MEDLINE]
Tags: Spine

    Spine

    Vertebral Compression Fracture Related to Pancreatic Cancer With Osteoblastic Metastasis: A Case Report and Literature Review.

    Chih Yp, Wu Wt, Lin Cl, Jou Hj, Huang Yh, Chen Lc, Chou Lw · Tuesday, June 14, 2016, 14:51
    http:--pt.wkhealth.com-pt-pt-core-templa http:--http://ift.tt/1Fkw4zC Related Articles
    Vertebral Compression Fracture Related to Pancreatic Cancer With Osteoblastic Metastasis: A Case Report and Literature Review.
    Medicine (Baltimore). 2016 Feb;95(5):e2670
    Authors: Chih YP, Wu WT, Lin CL, Jou HJ, Huang YH, Chen LC, Chou LW
    Abstract
    Compression fracture of the vertebral body is common in the older patients. The possible etiology like osteoporosis or cancer metastasis should be included as a possibility in the differential diagnosis for severe back pain, to prevent delays in diagnosis and treatment. More severe fractures can cause significant pain, leading to inability to perform activities of daily living, and life-threatening in the older patient.We report a rare case of a 61-year-old man suffering from severe lower back pain and intermittent abdominal fullness. He came to our clinic, where muscle power was normal, but could not stand up or change posture because of severe back pain. Plain film and magnetic resonance imaging of lumbar spine both revealed osteoblastic lesion at L2 spine. Abdomen computed tomography showed a mass at the pancreatic body. The pancreatic cancer with osteoblastic metastasis was diagnosed. After receiving multimodality therapy such as percutaneous vertebroplasty and pain controlling, we provided effective palliation of symptoms, aggressive rehabilitation program, and better quality of life.Our case highlights the benefits of multidisciplinary cancer treatment for such patient, preventing the complications such as immobilization accompanied with adverse effects like musculoskeletal, respiratory, and cardiovascular systems. All clinicians should be informed of the clinical findings to provide patients with suitable therapies and surveys. 
    PMID: 26844499 [PubMed - indexed for MEDLINE]
    Tags: Spine

      Spine

      177 Lu-OPS201 targeting somatostatin receptors: in vivo biodistribution and dosimetry in a pig model

      Tuesday, June 14, 2016, 14:51

      Abstract

      Background

      177Lu is used in peptide receptor radionuclide therapies for the treatment of neuroendocrine tumors. Based on the recent literature, SST2 antagonists are superior to agonists in tumor uptake. The compound OPS201 is the novel somatostatin antagonist showing the highest SST2 affinity. The aim of this study was to measure the in vivo biodistribution and dosimetry of 177Lu-OPS201 in five anesthetized Danish Landrace pigs as an appropriate substitute for humans to quantitatively assess the absorbed doses for future clinical applications.

      Results

      177Lu-OPS201 was obtained with a specific activity ranging from 10 to 17 MBq/μg. Prior to administration, the radiochemical purity was measured as s > 99.7 % in all cases. After injection, fast clearance of the compound from the blood stream was observed. Less than 5 % of the injected activity was presented in blood 10 min after injection. A series of SPECT/CT and whole-body scans conducted until 10 days after intravenous injection showed uptake mostly in the liver, spine, and kidneys. There was no visible uptake in the spleen. Blood samples were taken to determine the time-activity curve in the blood. Time-activity curves and time-integrated activity coefficients were calculated for the organs showing visible uptake. Based on these data, the absorbed organ dose coefficients for a 70-kg patient were calculated with OLINDA/EXM. For humans after an injection of 5 GBq 177Lu-OPS201, the highest predicted absorbed doses are obtained for the kidneys (13.7 Gy), the osteogenic cells (3.9 Gy), the urinary bladder wall (1.8 Gy), and the liver (1.0 Gy). No metabolites of 177Lu-OPS201 were found by radio HPLC analysis. None of the absorbed doses calculated will exceed organ toxicity levels.

      Conclusions

      The 177Lu-OPS201 was well tolerated and caused no abnormal physiological or behavioral signs. In vivo distributions and absorbed doses of pigs are comparable to those observed in other publications. According to the biodistribution data in pigs, presented in this work, the expected radiation exposure in humans will be within the acceptable range.

      from Cancer via xlomafota13 on Inoreader http://ift.tt/1XmdpSf
      via IFTTT
      Tags: Spine

        Spine

        177 Lu-OPS201 targeting somatostatin receptors: in vivo biodistribution and dosimetry in a pig model

        Tuesday, June 14, 2016, 14:51
        177 Lu-OPS201 targeting somatostatin receptors: in vivo biodistribution and dosimetry in a pig model:
        Abstract
        Background
        177Lu is used in peptide receptor radionuclide therapies for the treatment of neuroendocrine tumors. Based on the recent literature, SST2 antagonists are superior to agonists in tumor uptake. The compound OPS201 is the novel somatostatin antagonist showing the highest SST2 affinity. The aim of this study was to measure the in vivo biodistribution and dosimetry of 177Lu-OPS201 in five anesthetized Danish Landrace pigs as an appropriate substitute for humans to quantitatively assess the absorbed doses for future clinical applications.
        Results
        177Lu-OPS201 was obtained with a specific activity ranging from 10 to 17 MBq/μg. Prior to administration, the radiochemical purity was measured as s > 99.7 % in all cases. After injection, fast clearance of the compound from the blood stream was observed. Less than 5 % of the injected activity was presented in blood 10 min after injection. A series of SPECT/CT and whole-body scans conducted until 10 days after intravenous injection showed uptake mostly in the liver, spine, and kidneys. There was no visible uptake in the spleen. Blood samples were taken to determine the time-activity curve in the blood. Time-activity curves and time-integrated activity coefficients were calculated for the organs showing visible uptake. Based on these data, the absorbed organ dose coefficients for a 70-kg patient were calculated with OLINDA/EXM. For humans after an injection of 5 GBq 177Lu-OPS201, the highest predicted absorbed doses are obtained for the kidneys (13.7 Gy), the osteogenic cells (3.9 Gy), the urinary bladder wall (1.8 Gy), and the liver (1.0 Gy). No metabolites of 177Lu-OPS201 were found by radio HPLC analysis. None of the absorbed doses calculated will exceed organ toxicity levels.
        Conclusions
        The 177Lu-OPS201 was well tolerated and caused no abnormal physiological or behavioral signs. In vivo distributions and absorbed doses of pigs are comparable to those observed in other publications. According to the biodistribution data in pigs, presented in this work, the expected radiation exposure in humans will be within the acceptable range.
        from Cancer via ola Kala on Inoreader 
        via IFTTT
        Tags: Spine

          Spine

          177 Lu-OPS201 targeting somatostatin receptors: in vivo biodistribution and dosimetry in a pig model

          Tuesday, June 14, 2016, 14:51

          Abstract

          Background

          177Lu is used in peptide receptor radionuclide therapies for the treatment of neuroendocrine tumors. Based on the recent literature, SST2 antagonists are superior to agonists in tumor uptake. The compound OPS201 is the novel somatostatin antagonist showing the highest SST2 affinity. The aim of this study was to measure the in vivo biodistribution and dosimetry of 177Lu-OPS201 in five anesthetized Danish Landrace pigs as an appropriate substitute for humans to quantitatively assess the absorbed doses for future clinical applications.

          Results

          177Lu-OPS201 was obtained with a specific activity ranging from 10 to 17 MBq/μg. Prior to administration, the radiochemical purity was measured as s > 99.7 % in all cases. After injection, fast clearance of the compound from the blood stream was observed. Less than 5 % of the injected activity was presented in blood 10 min after injection. A series of SPECT/CT and whole-body scans conducted until 10 days after intravenous injection showed uptake mostly in the liver, spine, and kidneys. There was no visible uptake in the spleen. Blood samples were taken to determine the time-activity curve in the blood. Time-activity curves and time-integrated activity coefficients were calculated for the organs showing visible uptake. Based on these data, the absorbed organ dose coefficients for a 70-kg patient were calculated with OLINDA/EXM. For humans after an injection of 5 GBq 177Lu-OPS201, the highest predicted absorbed doses are obtained for the kidneys (13.7 Gy), the osteogenic cells (3.9 Gy), the urinary bladder wall (1.8 Gy), and the liver (1.0 Gy). No metabolites of 177Lu-OPS201 were found by radio HPLC analysis. None of the absorbed doses calculated will exceed organ toxicity levels.

          Conclusions

          The 177Lu-OPS201 was well tolerated and caused no abnormal physiological or behavioral signs. In vivo distributions and absorbed doses of pigs are comparable to those observed in other publications. According to the biodistribution data in pigs, presented in this work, the expected radiation exposure in humans will be within the acceptable range.
          Tags: Spine

            Spine

            Arthroscopic treatment of tibial eminence fracture: a systematic review of different fixation methods

            Osti, L., Buda, M., Soldati, F., Del Buono, A., Osti, R., Maffulli, N. · Tuesday, June 14, 2016, 14:51
            Introduction
            Arthroscopy procedures are the gold standard for the management of tibial spine avulsion. This review evaluates and compares different arthroscopic treatment options for tibial spine fractures.
            Source of data
            PubMed, Medline, Ovid, Google Scholar and Embase databases were systematically searched with no limit regarding the year of publication.
            Areas of agreement
            An arthroscopic approach compared with arthrotomy reduces complications such as soft-tissue lesions, post-operative pain and length of hospitalization.
            Areas of controversy
            The use of suture techniques, compared to cannulated screw technique, avoids a second surgery for removal of the screws, but requires longer immobilization and partial weight bearing.
            Growing points
            Clinical outcomes and radiographic results do not seem to differ in relation to the chosen method of fixation.
            Areas timely for developing research
            Further studies are needed to produce clear guidelines to define the best choice in terms of clinical outcomes, function and complications.
            Tags: Spine

              Spine

              Human neurexin-3{alpha} antibodies associate with encephalitis and alter synapse development

              Gresa-arribas, N., Planaguma, J., Petit-pedrol, M., Kawachi, I., Katada, S., Glaser, C. A., Simabukuro, M. M., Armangue, T., Martinez-hernandez, E., Graus, F., Dalmau, J. ·Tuesday, June 14, 2016, 14:51
              Objective:
              To report a novel autoimmune encephalitis in which the antibodies target neurexin-3α, a cell adhesion molecule involved in the development and function of synapses.
              Methods:
              Five patients with encephalitis and antibodies with a similar pattern of brain reactivity were selected. Antigen precipitation and determination of antibody effects on cultured rat embryonic neurons were performed with reported techniques.
              Results:
              Immunoprecipitation and cell-based assays identified neurexin-3α as the autoantigen of patients' antibodies. All 5 patients (median age 44 years, range 23–50; 4 female) presented with prodromal fever, headache, or gastrointestinal symptoms, followed by confusion, seizures, and decreased level of consciousness. Two developed mild orofacial dyskinesias, 3 needed respiratory support, and 4 had findings suggesting propensity to autoimmunity. CSF was abnormal in all patients (4 pleocytosis, 1 elevated immunoglobulin G [IgG] index), and brain MRI was abnormal in 1 (increased fluid-attenuated inversion recovery/T2 in temporal lobes). All received steroids, 1 IV immunoglobulin, and 1 cyclophosphamide; 3 partially recovered, 1 died of sepsis while recovering, and 1 had a rapid progression to death. At autopsy, edema but no inflammatory cells were identified. Cultures of neurons exposed during days in vitro (div) 7–17 to patients' IgG showed a decrease of neurexin-3α clusters as well as the total number of synapses. No reduction of synapses occurred in mature neurons (div 18) exposed for 48 hours to patients' IgG. Neuronal survival, dendritic morphology, and spine density were unaffected.
              Conclusion:
              Neurexin-3α autoantibodies associate with a severe but potentially treatable encephalitis in which the antibodies cause a decrease of neurexin-3α and alter synapse development.
              Tags: Spine

                Spine

                Relationship Between Bariatric Surgery and Bone Mineral Density: a Meta-analysis

                Tuesday, June 14, 2016, 14:51

                Abstract

                Background

                A meta-analysis regarding bone loss after bariatric surgery, designed to compare surgical and nonsurgical groups, has not yet been performed. Therefore, we performed a meta-analysis to compare the differences between bariatric surgical groups and nonoperated controls with regard to bone mineral density.

                Methods

                In March 2015, we performed a review of the literature using PubMed, EMBASE, and the Cochrane Library. The search focused on retrospective and prospective studies, including but not limited to randomized studies published in English.

                Results

                Among 1299 studies that were initially screened, ten met the selection criteria. For all types of bariatric surgery, bone density at the femoral neck was lower in the surgical group than in the nonsurgical control group (mean difference [MD] −0.05 g/cm2; 95 % confidence interval [CI], −0.07 to −0.02; p = 0.001); no difference in bone density was found between the two groups at the lumbar spine (MD −0.01 g/cm2; 95 % CI −0.07 to 0.05; p = 0.661). The analysis of Roux-en-Y gastric bypass showed similar results.

                Conclusion

                Bone density at the femoral neck decreased after bariatric surgery, compared to that in nonsurgical controls, whereas bone density at the lumbar spine did not show a difference between groups. Further larger scale studies with comparative nonsurgical controls are warranted to overcome the heterogeneity among studies in this analysis and to add evidence of possible bone loss subsequent to bariatric surgical procedures.
                Tags: Spine


                  The need to immobilise the cervical spine during cardiopulmonary resuscitation and electric shock administration in out-of-hospital cardiac arrest

                  Desroziers, M., Mole, S., Jost, D., Tourtier, J.-p. · Tuesday, June 14, 2016, 14:51
                  In cases of out-of hospital cardiac arrest (OHCA), falling to the ground can cause brain and neck trauma to the patient. We present a case of a man in his mid-60s who suffered from an OHCA resulting in a violent collapse. The patient received immediate cardiopulmonary resuscitation, but his spine was immobilised only after a large frontal haematoma was found. The resuscitation efforts resulted in return of spontaneous circulation and discharge from hospital. After this, doctors performed angioplasty, followed by a cardiopulmonary bypass. Later, CT scan examination reported a displaced and unstable fracture of the 6th vertebra without bone marrow involvement. The patient underwent a second operation. 40 days later, he was able to return home without sequela. This case shows the importance of analysing the circumstances of a fall, considering the possibility of two concomitant diagnoses and prioritising investigations and treatment.
                  Tags: Spine

                    Spine

                    A case report of acute injury in ankylosing spondylitis

                    Tuesday, June 14, 2016, 14:51
                    Publication date: Available online 13 June 2016
                    Source:Journal of Acute Disease
                    Author(s): Yu-Hang Yeh, Yu-Jang Su
                    Ankylosing spinal disorders tend to fracture after minor trauma because of its changed biomechanical properties. Herein we presented an ankylosing spinal disorders case with cervical spine fracture in a trauma after neck protection and surgical airway application. On CT scan of cervical spine, ankylosing spondylitis with an extension C4–C5 fracture was found. The patients' family decided not to receive operation to immobilize his cervical spine, then he was admitted to our surgical intensive care unit. He was discharged against medical advice two months later with a permanent tracheostomy with ventilator dependence due to high-level spinal cord injury. Timely identification of unstable fractures is instrumental in avoiding adverse neurologic sequela.
                    Tags: Spine



                    from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1VX2iyc
                    via IFTTT

                    Dermatology Unread articles



                      Dermatology

                      An observational study to evaluate the long-term outcomes of treatment with etanercept in patients with plaque-type psoriasis

                      T. Luger, R.e. Schopf, A. Schwanke, S. Langhammer, T. Meng, P.a. Löschmann ·Tuesday, June 14, 2016, 14:48

                      Abstract

                      Background

                      There is an unmet need for long-term, real-life data on the effect of a drug-free interval between treatment cycles in patients with plaque psoriasis being treated with etanercept, which is licensed for intermittent and continuous treatment.

                      Objective

                      The aim of this study was to determine the average duration of the drug-free interval between etanercept treatment cycles in patients with plaque psoriasis.

                      Methods

                      This was a non-interventional, open-label, multicentre, prospective study in patients for whom the decision had already been made to initiate treatment with etanercept during routine practice in German centres. Clinical outcomes were documented over 36 months with study visits every 12 weeks. The primary endpoint was the duration of the treatment-free interval between etanercept treatment cycles (24 weeks/cycle). Secondary endpoints assessed efficacy [Psoriasis Area and Severity Index (PASI), Body Surface Area (BSA), static Physician's Global Assessment (sPGA)], health-related outcomes [EuroQol-5 Dimensions (EQ-5D), Dermatology Life Quality Index (DLQI)] and safety.

                      Results

                      A total of 955 patients were enrolled from 224 centres; 926 of these were included in the safety analyses and 720 patients from the safety population were included in the efficacy analysis. The mean duration of drug-free intervals was 12.9 ± 12.8 weeks. Efficacy and health-related quality of life outcomes measures showed consistent improvement that occurred within 12 weeks of treatment with etanercept. There was a descriptive difference between the continuous and intermittent treatment subgroups, as subjects in the latter showed a deterioration at the first visit following an interval. However, retreatment with etanercept resulted in a clinical efficacy identical to the initial effect. The incidence of physician-assessed, drug-related adverse events and serious adverse events was 13.1% and 1.9%, respectively.

                      Conclusion

                      The mean duration of drug-free intervals was relatively short, most patients experienced improvements in disease activity and health-related quality of life within 12 weeks of either continuous or intermittent treatment with etanercept, and there were no new safety signals. ClinicalTrials.gov identifier: NCT00708708.
                      Tags: Dermatology

                        Dermatology

                        A Rare Presentation of a Dermoid Cyst with Draining Sinus in a Child: Case Report and Literature Review

                        Chen Yan, David W. Low · Tuesday, June 14, 2016, 14:48

                        Abstract

                        Orbitofacial dermoid cysts in children are treated using surgical excision. Dermoid cysts of the frontotemporal region usually present as superficial, slow-growing masses without deep extension. We report a rare case wherein a frontotemporal dermoid in a 21-month-old girl presented with a draining sinus tract to the skin and extended intracranially through the sphenoid bone. It was removed surgically and a dermoid cyst was removed from the frontotemporal region, extending superficially from the skin sinus tract through the sphenoid bone and attaching to the dura of the anterior temporal lobe. In addition to our case presentation, a literature review was performed to identify the few reported similar cases in the published literature, the combination of which suggests that frontotemporal dermoid cysts with associated draining sinus tracts may require preoperative imaging with computed tomography or magnetic resonance imaging before surgical intervention because of the high likelihood of intracranial extension.
                        Tags: Dermatology

                          Dermatology

                          Catastrophic cryofibrinogenaemia associated with chronic lymphocytic leukaemia and salvage therapy using plasmapheresis and cyclophosphamide

                          M. Algain, R. Damade, F. Aucouturier, J. Rivet, M. Jachiet, M. Malphettes, G. Hickman, R. Szalat, A. Saussine, A. De Masson, A. Petit, M. Rybojad, M. Bagot, B. Arnulf, J.d. Bouaziz · Tuesday, June 14, 2016, 14:48
                          Tags: Dermatology

                            Dermatology

                            Histopathology and reflectance confocal microscopy features of photodamaged skin and actinic keratosis

                            J.m. Tan, D. Lambie, S. Sinnya, A. Sahebian, H.p. Soyer, T.w. Prow, M. Ardigò ·Tuesday, June 14, 2016, 14:48

                            Abstract

                            Background

                            Actinic keratosis (AK) usually co-exists in areas of severe photodamage, but the clinical applicability of reflectance confocal microscopy (RCM) in diagnosing AK currently depends on a set of parameters yet to be defined in comparison to photodamaged skin (PD).

                            Objective

                            To correlate the RCM features of PD and AK with histopathology.

                            Methods

                            Twenty participants with a mean age of 64 years and skin phototype I and II were studied. RCM was performed on two PD and one AK within a field of 25 cm2 on the left dorsal forearm, followed by shave biopsies. Blinded evaluation of the histopathological and RCM images using established parameters in AK were performed retrospectively in consensus with an expert confocalist, correlated with the histopathological diagnosis by a board-certified dermatopathologist.

                            Results

                            A total of 57/60 areas were included. There were 43/57 (75%) and 14/57 (25%) histopathologically confirmed PD and AK respectively. Individual corneocytes, stratum corneum disruption, dermal inflammatory cells, increased vascularity/dilated vessels and solar elastosis were detected in PD and AK upon histopathology and RCM. The features in favour of AK were parakeratosis, hyperkeratosis, more severe keratinocyte pleomorphism and architectural disruption, and the presence of epidermal inflammatory cells. PD also demonstrated keratinocyte pleomorphism and architectural disruption though this was generally less severe than AK. A small subset of PD exhibited a comparable degree of keratinocyte pleomorphism and architectural disruption to the AKs in the cohort.

                            Conclusions

                            The viable epidermis demonstrates PD and AK to be part of a disease continuum corresponding to field cancerization. Individual corneocytes, stratum corneum disruption, dermal inflammatory cells, increased vascularity/dilated vessels and solar elastosis may be present in PD; whereas, parakeratosis and hyperkeratosis may represent the key to distinguishing AK from PD using RCM. The significance of epidermal inflammatory cells in the RCM diagnosis of AK remains to be elucidated.
                            Tags: Dermatology

                              Dermatology

                              CDK4/6-Inhibitoren

                              Tuesday, June 14, 2016, 14:48
                              Tags: Dermatology

                                Dermatology

                                Entwicklungen der Immunmodulation nach Transplantation im Hinblick auf De-novo-Malignome und Tumorrezidive

                                Tuesday, June 14, 2016, 14:48

                                Zusammenfassung

                                Hintergrund

                                Organtransplantierte Patienten haben ein erhöhtes Risiko, maligne Tumoren zu entwickeln. Im langfristigen Verlauf nach Organtransplantation stellen maligne Tumoren nach den kardiovaskulären Erkrankungen die zweithäufigste Todesurasche dar. Ziel dieses Reviews ist eine überblickende Darstellung der Zusammenhänge zwischen Immunmodulation und Tumorentstehung nach Organtransplantation.

                                Ergebnisse und Schlussfolgerung

                                Neben individuellen Risikofaktoren werden die immunologischen Veränderungen nach Organtransplantation als Ursache des erhöhten Krebsrisikos angesehen. Histokompatibilität, HLA-Status, die kumulative Immunsuppressionsdosis in der Induktions-, Erhaltungs- und Abstoßungsbehandlung, das mit spezifischen Immunsuppressiva assoziierte Malignitätsrisiko sowie eine erhöhte Inzidenz onkogener viraler Infektionen scheinen zum erhöhten Krebsrisiko nach Organtransplantation beizutragen. Ein gründliches Tumorscreening vor und nach Transplantation, antivirale Prophylaxen und eine so niedrig wie möglich dosierte Immunsuppression sind gegenwärtige Strategien, um das Risiko für die Entstehung maligner Tumore nach Transplantation zu senken. Die Entwicklung neuer Immunsuppressiva und Protokolle zur Toleranzinduktion und klinische Erfahrungen mit systemischen und lokalen immunbasierten Tumortherapien können zukünftig ebenso dazu beitragen wie ein besseres Verständnis der Pathomechanismen der Kanzerogenese unter Immunsuppression.
                                Tags: Dermatology

                                  Dermatology

                                  New treatment offers hope for children with debilitating skin and muscle disease

                                  Tuesday, June 14, 2016, 14:48
                                  Patients who have failed multiple drug treatments show significant improvements.
                                  Tags: Dermatology

                                    Dermatology

                                    Triple paradoxical reaction due to adalimumab

                                    J.f. Mir-bonafe, A. Lopez-ferrer, A. Laiz, L. Puig · Tuesday, June 14, 2016, 14:48
                                    Tags: Dermatology

                                      Dermatology

                                      Next-generation sequencing identified a novel mutation of COL7A1 in a Chinese pedigree of dystrophic epidermolysis bullosa

                                      S. Zheng, X.g. Xu, Y. Lv, X.-h. Gao, H.d. Chen · Tuesday, June 14, 2016, 14:48
                                      Tags: Dermatology

                                        Dermatology

                                        Sentinel lymph node biopsy versus PET-CT in AJCC stages I and II of melanoma

                                        M.a. Chessa, E. Dika, A. Patrizi, P.a. Fanti, B.m. Piraccini, G. Veronesi, S. Diodato, S. De Vivo, S. Fanti · Tuesday, June 14, 2016, 14:48
                                        cover.gif?v=1&s=4bb140294ab30f971ec9e9e5
                                        Tags: Dermatology

                                          Dermatology

                                          Atypical Forms of Hand, Foot, and Mouth Disease: A Prospective Study of 47 Italian Children

                                          Iria Neri, Arianna Dondi, Andreas Wollenberg, Lorenza Ricci, Giampaolo Ricci, Giulia Piccirilli, Tiziana Lazzarotto, Annalisa Patrizi · Tuesday, June 14, 2016, 14:48

                                          Abstract

                                          Background

                                          Atypical forms of hand, foot, and mouth disease (HFMD) caused by coxsackievirus A6 have been reported in recent years. High fever and severe cutaneous lesions are common, whereas neurologic complications are rare. Eczematous areas of patients with atopic dermatitis show more lesions. The goal of the current study was to describe the clinical characteristics of children with atypical HFMD and to investigate the involvement of the different enterovirus serotypes associated.

                                          Methods

                                          All patients referred to our service for atypical HFMD from January 2012 to February 2014 were enrolled and classified as having the diffuse form (lesions extended to the trunk), the acral form (lesions with a mainly acral distribution), or eczema coxsackium (lesions on preexisting eczematous areas).

                                          Results

                                          Data from 47 patients were analyzed (median age 22 months [range 4–84 mos]); viral genotyping was performed in 11 cases. Sixty-two percent of the subjects developed the acral form, 23% eczema coxsackium, and 15% the diffuse form. Most patients had a nonclassical vesicular eruption and moderate to severe extent of cutaneous involvement. Approximately 80% of patients had palmoplantar purpuric macules. Most children younger than 2 years old had the acral form, most patients with eczema coxsackium were age 2 years and older, and the diffuse form was similarly distributed between the two age groups. Coxsackievirus A6 was detected in 9 of 11 genotyped cases.

                                          Conclusion

                                          Our prospective study allowed the identification of three HFMD phenotypes differing from the classical form. Clinical care of these patients should include symptomatic treatment of extracutaneous features and, if necessary, hospitalization for complications.
                                          Tags: Dermatology

                                            Dermatology

                                            Ultrasound Diagnosis and Staging in Pediatric Hidradenitis Suppurativa

                                            Ximena Wortsman, Carolyn Rodriguez, Carolina Lobos, Gonzalo Eguiguren, Maria Teresa Molina · Tuesday, June 14, 2016, 14:48

                                            Abstract

                                            Hidradenitis suppurativa (HS) can affect children, and ultrasound has been proven to be useful in diagnosis and staging. The sonographic characteristics of HS in children have not been reported. We studied color Doppler ultrasound images of children (≤15 years old; n = 12) with clinically and sonographically positive criteria for HS. Sonographic scoring of hidradenitis suppurativa (SOS-HS) was used to stage the cases sonographically. Subclinical pseudocysts were found in 92% of the cases, fluid collections in 83%, and fistulous tracts in 58%. Retained hair tracts in the fluid collections and fistulous tracts were present in 100% of patients; 67% of cases were SOS-HS stage II. In 92% of cases, management was modified after the ultrasound examination. In conclusion, ultrasound can be a reliable and safe imaging tool to support diagnosis and staging and may help in the noninvasive monitoring of treatment in children.
                                            Tags: Dermatology

                                              Dermatology

                                              Prognosis and Management of Congenital Hair Shaft Disorders without Fragility—Part II

                                              Gaurav Singh, Mariya Miteva · Tuesday, June 14, 2016, 14:48

                                              Abstract

                                              Hair shaft disorders are characterized by congenital or acquired abnormalities of the hair shaft. The objective of this study was to review the literature regarding the prognosis and treatment options for hair shaft disorders. We used keywords in the search engines PubMed and Medline to identify all publications in English related to the prognosis and management of hair shaft disorders. Data were extracted from 96 articles that met search criteria. Findings were limited to case reports and small case series, as no studies were found. Disorders that improve in childhood include pili torti, trichorrhexis invaginata, woolly hair, and pili trianguli et canaliculi. Others, such as trichorrhexis nodosa, monilethrix, pili annulati, and pili bifurcati, improve with minoxidil. Oral retinoids have been found to improve hair abnormalities in trichorrhexis invaginata and monilethrix. There is no specific treatment for congenital hair shaft abnormalities. Gentle hair care is the mainstay of care for hair shaft disorders associated with fragility. Practices for gentle care include no brushing, backcombing, chemical products, tight braids, heat exposure, or mechanical grooming. Furthermore, any inherited or congenital disorder requires genetic counseling as part of management.
                                              Tags: Dermatology

                                                Dermatology

                                                Prognosis and Management of Congenital Hair Shaft Disorders with Fragility—Part I

                                                Gaurav Singh, Mariya Miteva · Tuesday, June 14, 2016, 14:48

                                                Abstract

                                                Hair shaft disorders are characterized by congenital or acquired abnormalities of the hair shaft. The objective was to review the literature regarding the prognosis and treatment options of hair shaft disorders. We used keywords in the search engines PubMed and Medline to identify all publications in the English language related to the prognosis and management of hair shaft disorders. Data were extracted from 96 articles that met search criteria. Findings were limited to case reports and small case series, as no studies were found. Disorders that improve in childhood include pili torti, trichorrhexis invaginata, wooly hair, and pili trianguli et canaliculi. Others, such as trichorrhexis nodosa, monilethrix, pili annulati, and pili bifurcati improve with minoxidil. Oral retinoids have improved hair abnormalities in trichorrhexis invaginata and monilethrix. There is no specific treatment for congenital hair shaft abnormalities. Gentle hair care is the mainstay of care for hair shaft disorders associated with fragility. Practices for gentle care include no brushing, backcombing, chemical products, tight braids, heat exposure, or mechanical grooming. Any inherited or congenital disorder requires genetic counseling as part of management.
                                                Tags: Dermatology

                                                  Dermatology

                                                  Late-Onset Nail Changes Associated with Hand, Foot, and Mouth Disease: A Clinical Analysis of 56 Cases

                                                  Dong-ling Long, Shi-yuan Zhu, Cai-zi Li, Cui-yan Chen, Wan-tao Du, Xi Wang · Tuesday, June 14, 2016, 14:48

                                                  Abstract

                                                  Objectives

                                                  To investigate the development and clinical characteristics of nail changes in hand, foot, and mouth disease (HFMD).

                                                  Methods

                                                  A telephone survey was conducted with the parents of patients diagnosed with HFMD in the Fourth General Hospital of Nanhai from June to August 2013 to document nail changes within 3 months of diagnosis of HFMD.

                                                  Results

                                                  Valid survey results were obtained from 273 cases. Definitive nail changes were identified in 56 patients (20.5%). More boys (25.8%) than girls (10.6%) (p < 0.01) showed changes. The age distribution ranged from 1 to 5 years, and nail changes were rare in children younger than 1 year of age (p < 0.01). Nail changes were usually seen 1 to 2 months after the onset of HFMD and lasted for 1 to 8 weeks, most for approximately 4 weeks. Toenails or fingernails could be affected and the changes were more likely to occur synchronously. Fingernails were more commonly involved than toenails. When both fingernails and toenails were involved, this typically occurred synchronously. Although there were cases with all toenails and fingernails involved (16.1%), we did not encounter any instances involving 13 to 19 nails. The nail changes mainly presented as onychomadesis. Spontaneous recovery without special treatment was the course for all patients. No relapse or new nail involvement was identified.

                                                  Conclusions

                                                  Nail change associated with HFMD usually occurs within 1 to 2 months after onset, mainly presents as onychomadesis, and is a self-limited process. Possible mechanisms are discussed.
                                                  Tags: Dermatology

                                                    Dermatology

                                                    Risk Factors for Premature Hair Graying in Young Turkish Adults

                                                    Asli Akin Belli, Fatma Etgu, Seyran Ozbas Gok, Bilge Kara, Gursoy Dogan · Tuesday, June 14, 2016, 14:48

                                                    Abstract

                                                    Background

                                                    Premature hair graying (PHG) is a common condition resulting in loss of self-esteem. Studies investigating PHG risk factors for both sexes with a large number of patients are scarce. We sought to investigate the socioclinical risk factors for PHG in young Turkish men and women and the differences between the sexes.

                                                    Methods

                                                    A cross-sectional study was conducted in 1,119 participants who answered a survey about PHG and some socioclinical characteristics between February and July 2015. The number of gray hairs, onset age of hair graying, and family history of PHG were asked about, as well as demographic characteristics, anthropometric measures, body mass index, smoking, alcohol consumption, sports life, diet, medical history, educational status, occupation, marital status, monthly income, and Fitzpatrick skin type.

                                                    Results

                                                    Of 1,119 participants, 315 (28.1%) had PHG and 804 did not. Maternal and paternal PHG, alcohol consumption, presence of chronic disease, educational status, hair loss, perceived stress scale (PSS) score, age, and height were significantly higher in subjects with PHG. Rates of maternal and paternal PHG were high in women with PHG, and the rate of paternal PHG was high in men with PHG. According to the multivariate ordinal regression analysis, PSS score, age, hair loss, and family history of PHG were correlated with the severity of PHG.

                                                    Conclusion

                                                    PHG is closely related to factors causing oxidative stress, such as emotional stress, alcohol consumption, and chronic diseases in genetically predisposed men and women.
                                                    Tags: Dermatology

                                                      Dermatology

                                                      Asymmetrical proliferative pattern loss linked to cyclin D1 overexpression during malignant transformation of the lip epithelium

                                                      N.g. Garcia, M.a. González-moles, I. Ruiz-ávila, M. Bravo, P. Ramos-garcía, E.m. Minicucci, M.a.c. Domingues, D.t. Oliveira · Tuesday, June 14, 2016, 14:48
                                                      cover.gif?v=1&s=4bb140294ab30f971ec9e9e5

                                                      Abstract

                                                      Background

                                                      There is inadequate knowledge on the involvement of oncogenic mechanisms linked to the cyclin (CCND1) gene in lip squamous cell carcinoma (LSCC).

                                                      Objective

                                                      The aim of this study was to analyse the implication of cyclin D1 in the malignant transformation of lip lesions.

                                                      Methods

                                                      We immunohistochemically studied 45 actinic cheilitis cases (15 mild dysplasia, 15 moderate dysplasia, 15 severe dysplasia/carcinoma in situ), 30 LSCC cases with adjacent non-tumour epithelium and 15 normal oral epithelium samples for detection of cyclin D1, β-catenin and Ki-67.

                                                      Results

                                                      Cyclin D1 and Ki-67 expressions were significantly increased in the basal layer of premalignant epithelia and peripheral layers of tumour nests vs. controls. Premalignant epithelia had lost their asymmetrical proliferative pattern.

                                                      Conclusion

                                                      Lip carcinogenesis was associated with loss of the asymmetrical proliferative pattern, a preventive mechanism against lip oncogenesis, and with cyclin D1 overexpression.
                                                      Tags: Dermatology

                                                        Dermatology

                                                        Short-term efficacy and safety of new biologic agents targeting IL-23/Th17 pathway for moderate to severe plaque psoriasis: a systematic review and network meta-analysis

                                                        F. Gómez-garcía, D. Epstein, B. Isla-tejera, A. Lorente, A. Vélez García-nieto, J. Ruano ·Tuesday, June 14, 2016, 14:48

                                                        Abstract

                                                        A new generation of biologics targeting IL-23/Th17 pathway has been developed. This study aimed to assess the short-term effectiveness and safety of these new agents using a network meta-analysis. Twenty seven randomized clinical trials (n=10,629) were identified by a comprehensive systematic literature review (PROSPERO 2015:CRD42015025472). Quality of evidence was assessed following Cochrane compliant rules and GRADE approach. Efficacy and safety outcomes at weeks 10-16 were compared using a random-effects network meta-analysis within a frequentist framework to estimate pooled odds ratios (OR) of direct and indirect comparisons among the therapeutic options. There were 6 direct drug-to-drug comparisons in the network, with a high degree of consistency between the direct and the indirect evidence. From the available evidence, infliximab 5mg.kg-1 every eight weeks (OR: 118.89; 95%CI: 60.91-232.04) and secukinumab 300mg every four weeks (OR: 87.07;95%CI: 55.01-137.82) are shown as among the most effective short-term treatment, but are ranked as the biologic most likely to produce any adverse event (AE) or an infectious AE, respectively. Ustekinumab 90mg every twelve weeks, the third most efficacious (OR: 73.67; 95%CI: 46.97-115.56), was the only agent that did not show increased risk of adverse events when compared with placebo. Treatment recommendations should also consider long term outcomes and costs.
                                                        This article is protected by copyright. All rights reserved.
                                                        Tags: Dermatology

                                                          Dermatology

                                                          Statin use and the risk of herpes zoster: a nested case-control study using primary care data from the UK Clinical Research Practice Datalink

                                                          A. Matthews, M. Turkson, H. Forbes, S.m. Langan, L. Smeeth, K. Bhaskaran · Tuesday, June 14, 2016, 14:48

                                                          Abstract

                                                          Background

                                                          Statins are commonly prescribed worldwide and recent evidence suggests they may increase the risk of herpes zoster.

                                                          Objective

                                                          To quantify the effect of statin exposure on the risk of zoster in the UK.

                                                          Methods

                                                          A matched case-control study was conducted using data from UK primary care and hospital records. Patients >18 years with an incident diagnosis of zoster were matched to up to four controls on age, sex and general practice. Exposures were: ever use of a statin; daily dosage of most recent statin prescription; time since most recent statin prescription. The primary outcome was an incident diagnosis of zoster. Odds ratios were estimated from conditional logistic regression and adjusted for potential confounders.

                                                          Results

                                                          A total of 144,959 incident cases of zoster were matched to 549,336 controls. Adjusted analysis suggested strong evidence for an increase in risk of zoster related to statin exposure (OR:1.13, 95% CI:1.11,1.15). There was also an increasing risk with increasing dose in current and recent users (p-trend<0.001), and an attenuation of excess risk in previous users as time since last exposure increased (p-trend<0.001).

                                                          Conclusion

                                                          These findings are consistent with the hypothesis that statin therapy leads to an increase in the risk of zoster.
                                                          This article is protected by copyright. All rights reserved.
                                                          Tags: Dermatology

                                                            Dermatology

                                                            The SCAR Scale (Scar Cosmesis Assessment and Rating Scale): Development and validation of a new outcome measure for postoperative scar assessment

                                                            J. Kantor · Tuesday, June 14, 2016, 14:48
                                                            In order to effectively discriminate between various surgical interventions, it is critical to utilize a valid and feasible outcome measure for postoperative scar quality. Despite the large number of studies published in the dermatology, general surgery, and plastic surgery literature on the relative merits of various surgical techniques, no ideal scar scale exists to effectively assess the quality of postoperative scars. Until now, studies have relied on one of several scales for scar rating,1-5 many of which were developed for burn, rather than linear, scars. Moreover, none of these scales were developed or validated by dermatologists, none were developed expressly for tracking the evolution of linear postoperative scars, and none rigorously included input from patients in its development.
                                                            This article is protected by copyright. All rights reserved.
                                                            Tags: Dermatology



                                                            from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1UQMXtF
                                                            via IFTTT

                                                            Αρχειοθήκη ιστολογίου